Internal Medicine, Medical Oncology · Boone, NC
NPI
1457319931
Since 2006
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
1200 State Farm Rd
Boone, NC, 28607
Phone (828) 262-4332
Groups this clinician bills Medicare through
Medicare paid, 2024
$5.2M
245,412 services
Medicare patients, 2024
1,272
Average age 74
Drug cost, 2024
$12.6M
3,437 prescriptions
Company payments, 2025
$198
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ovidiu G Negrea was code J9299 (injection, nivolumab, 1 mg), 25,080 times for 12 patients. In total Ovidiu G Negrea billed 245,412 services in 134 codes, and Medicare paid $5.2M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-09-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J9299 Injection, nivolumab, 1 mg | Office | 25,080 | 12 | $24.57 | $616K |
| J0185 Injection, aprepitant, 1 mg | Office | 21,712 | 43 | $1.34 | $29K |
| J9271 Injection, pembrolizumab, 1 mg | Office | 18,700 | 20 | $44.66 | $835K |
| J9263 Injection, oxaliplatin, 0.5 mg | Office | 13,800 | 15 | $0.06 | $773 |
| J9267 Injection, paclitaxel, 1 mg | Office | 10,016 | 18 | $0.08 | $816 |
| J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 9,460 | 17 | $2.35 | $22K |
| J1437 Injection, ferric derisomaltose, 10 mg | Office | 8,700 | 76 | $15.72 | $137K |
| J0897 Injection, denosumab, 1 mg | Office | 4,680 | 37 | $20.01 | $94K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 3,602 | 82 | $0.09 | $322 |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 3,391 | 68 | $0.73 | $2,483 |
| 85025 Blood Count | Office | 2,650 | 844 | $7.57 | $20K |
| 36415 Venipuncture Blood Collection | Office | 2,280 | 846 | $8.58 | $20K |
| 99213 Office E&M - Established | Office | 1,158 | 719 | $59.61 | $69K |
| 96413 Chemotherapy Administration | Office | 778 | 128 | $88.70 | $69K |
| 96375 Injection Administration | Office | 748 | 98 | $10.74 | $8,035 |
By year: 2022 $4.0M for 196,597 services; 2023 $4.1M for 220,531 services; 2024 $5.2M for 245,412 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 2,650 | 844 | $7.57 | $20K |
| 36415 Venipuncture Blood Collection | 2,280 | 846 | $8.58 | $20K |
| 85045 Blood Count | 52 | 49 | $3.91 | $203 |
| 81002 Clinical Chemistry | 35 | 20 | $3.41 | $119 |
Medicare prescription drug claims, 2024
In 2024, the drug Ovidiu G Negrea prescribed most often to Medicare patients was Eliquis (Apixaban), with 187 prescriptions and refills. In total Ovidiu G Negrea wrote 3,437 Medicare prescriptions that cost $12.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 187 | 267 | 43 | $148K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 173 | 173 | 50 | $3,514 |
| Anastrozole Generic | 162 | 336 | 54 | $3,147 |
| Revlimid Lenalidomide | 149 | 149 | 23 | $2.8M |
| Hydroxyurea Generic | 125 | 272 | 35 | $2,742 |
| Oxycodone Hcl Generic | 121 | 121 | 34 | $1,529 |
| Prochlorperazine Maleate Generic | 108 | 110 | 70 | $2,034 |
| Brukinsa Zanubrutinib | 102 | 102 | 14 | $1.5M |
| Gabapentin Generic | 100 | 122 | 29 | $1,617 |
| Letrozole Generic | 89 | 227 | 34 | $1,998 |
| Prednisone Generic | 82 | 112 | 32 | $575 |
| Ondansetron Odt Ondansetron | 80 | 80 | 49 | $1,569 |
| Abiraterone Acetate Generic | 80 | 80 | 12 | $159K |
| Acyclovir Generic | 76 | 142 | 26 | $1,461 |
| Ondansetron Hcl Generic | 75 | 85 | 53 | $2,612 |
Brand drugs: 1,069 claims; generic drugs: 2,368 claims; opioid claims: 474.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ovidiu G Negrea $198 ($198 in general payments such as food, travel and fees) from 5 companies. The largest payer was Adaptive Biotechnologies Corporation with $150.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.